The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients

Journal of Neuro-Oncology

Volumn 98, Issue 1, 2010, Pages 41-47

  Yoshida, Yuya ^a   Nakada, Mitsutoshi ^a   Harada, Tomoya ^a   Tanaka, Shingo ^a   Furuta, Takuya ^a   Hayashi, Yasuhiko ^a   Kita, Daisuke ^a   Uchiyama, Naoyuki ^a   Hayashi, Yutaka ^a   Hamada, Jun Ichiro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Glioblastoma; MIB 1 labeling index; S1P1 receptor; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CHILD; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, LYSOSPHINGOLIPID; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 77953610249     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0064-5     Document Type: Article

References (45)

1. DN Louis H Ohgaki OD Wiestler, et al. 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 10.1007/s00401-007-0243-4 17618441 (Pubitemid 47103521)
2. J Gerdes U Schwab H Lemke, et al. 1983 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation Int J Cancer 31 13 20 10.1002/ijc.2910310104 1:STN:280: DyaL3s7lvF2nsA%3D%3D 6339421 (Pubitemid 13179545)
3. G Key MH Becker B Baron, et al. 1993 New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope Lab Invest 68 629 636 1:CAS:528:DyaK3sXmtVWnsbs%3D 7685843
4. AL Johannessen SH Torp 2006 The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas Pathol Oncol Res 12 143 147 10.1007/BF02893360 16998593
5. AM Ralte MC Sharma AK Karak, et al. 2001 Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors Pathol Oncol Res 7 267 278 10.1007/BF03032383 1:STN:280:DC%2BD387kvFSgsg%3D%3D 11882906
6. JF Reavey-Cantwell RI Haroun M Zahurak, et al. 2001 The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature J Neurooncol 55 195 204 10.1023/A:1013845004294 1:STN:280:DC%2BD387isFGhsg%3D%3D 11859975 (Pubitemid 34134044)
7. E Karamitopoulou E Perentes I Diamantis, et al. 1994 Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material Acta Neuropathol 87 47 54 10.1007/BF00386253 1:CAS:528:DyaK2cXltlWit74%3D 7511316
8. H Khalid S Shibata M Kishikawa, et al. 1997 Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors Cancer 80 2133 2140 10.1002/(SICI)1097-0142(19971201)80:11<2133::AID-CNCR13>3.0. CO;2-# 1:CAS:528:DyaK2sXnvV2itbg%3D 9392336 (Pubitemid 27506027)
9. PK Sallinen HK Haapasalo T Visakorpi, et al. 1994 Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples J Pathol 174 275 282 10.1002/path.1711740407 1:STN:280:DyaK2M7ptVKruw%3D%3D 7884589
10. X Di T Nishizaki K Harada, et al. 1997 Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1 J Exp Clin Cancer Res 16 389 394 1:STN:280:DyaK1c7ms1Wjuw%3D%3D 9505211 (Pubitemid 28083539)
11. DW Hsu DN Louis JT Efird, et al. 1997 Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas J Neuropathol Exp Neurol 56 857 865 10.1097/00005072-199708000-00003 1:STN:280: DyaK2svgt1yktQ%3D%3D 9258255
12. S Enestrom L Vavruch B Franlund, et al. 1998 Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas Neurochir 44 25 30 1:STN:280:DyaK1cvivFyksw%3D%3D
13. SH Torp 2002 Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies Clin Neouropathol 21 252 257 1:STN:280:DC%2BD38jis12msg%3D%3D
14. L Neder BO Colli HR Machado, et al. 2004 MIB-1 labeling index in astrocytic tumors-a clinicopathologic study Clin Neuropathol 6 262 270
15. H Wakimoto M Aoyagi T Nakayama, et al. 1996 Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77 373 380 10.1002/(SICI)1097-0142(19960115) 77:2<373::AID-CNCR21>3.0.CO;2-Y 1:STN:280:DyaK283itlektA%3D%3D 8625247 (Pubitemid 26025528)
16. PE McKeever DA Ross MS Strawderman, et al. 1997 A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters J Neuropathol Exp Neurol 56 798 805 1:STN:280:DyaK2szlsVKnuw%3D%3D 9210876
17. D Schiffer P Cavalla A Chio, et al. 1997 Proliferative activity and prognosis of low-grade astrocytomas J Neurooncol 34 31 35 10.1023/A: 1005755119526 1:STN:280:DyaK2szltlyisg%3D%3D 9210051 (Pubitemid 27270250)
18. PE McKeever MS Strawderman B Yamini, et al. 1998 MIB-1 proliferation index predicts survival among patients with grade II astrocytoma J Neuropathol Exp Neurol 57 931 936 10.1097/00005072-199810000-00005 1:STN:280: DyaK1M%2FgtVWrsA%3D%3D 9786243
19. SH Torp M Alsaker 2002 Ki-67 immunoreactivity, basic fibroblast growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas Pathol Res Pract 198 261 265 1:CAS:528:DC%2BD38Xlt1Ohtrs%3D 12049334
20. RJ Scott PA Hall JS Haldane, et al. 1991 A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction J Pathol 165 173 178 10.1002/path.1711650213 1:STN:280:DyaK38%2FnvFWltg%3D%3D 1683905
21. D McCormick H Chong C Hobbs, et al. 1993 Detection of the Ki-67 antigen in fixed and wax embedded sections with the monoclonal antibody Mib1 Histopathology 22 355 360 10.1111/j.1365-2559.1993.tb00135.x 1:STN:280:DyaK3s3ptlWktg%3D%3D 8514278
22. JS Smith I Tachibana SM Passe, et al. 2001 PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 1246 1256 10.1093/jnci/93.16.1246 1:CAS:528:DC%2BD3MXms1Ortbw%3D 11504770
23. G Choe S Horvath TF Cloughesy, et al. 2003 Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo Cancer Res 63 2742 2746 1:CAS:528:DC%2BD3sXkt1aju7w%3D 12782577
24. G Reifenberger VP Collins 2004 Pathology and molecular genetics of astrocytic gliomas J Mol Med 82 656 670 10.1007/s00109-004-0564-x 1:CAS:528:DC%2BD2cXotlKqu7Y%3D 15316624 (Pubitemid 39468490)
25. E Ranza A Facoetti P Morbini, et al. 2007 Exogenous platelet-derived growth factor (PDGF) induces human astrocytoma cell line proliferation Anticancer Res 27 2161 2166 1:CAS:528:DC%2BD2sXpvFCitb4%3D 17695499
26. S Spiegel S Milstien 2003 Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 397 407 10.1038/nrm1103 1:CAS:528:DC%2BD3sXjtlalt7o%3D 12728273 (Pubitemid 36565571)
27. T Hla 2004 Physiological and pathological actions of sphingosine 1-phosphate Semin Cell Dev Biol 15 513 520 10.1016/j.semcdb.2004.05.002 1:CAS:528:DC%2BD2cXmtVaitb4%3D 15271296 (Pubitemid 38953947)
28. Y Takuwa N Takuwa N Sugimoto 2002 The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities J Biochem 131 767 771 1:CAS:528:DC%2BD38XlslKktL8%3D 12038970
29. N Young JR Van Brocklyn 2006 Signal transduction of sphingosine-1- phosphate G protein-coupled receptors Sci World J 6 946 966 1:CAS:528: DC%2BD28Xpt1Chtr0%3D
30. Yoshida Y, Nakada M, Sugimoto N, Harada T, Hayashi Y, Kita D, Uchiyama N, Hayashi Y, Yachie A, Takuwa Y, Hamada JI (2009) Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival. Int J Cancer 9999(999A). doi: 10.1002/ijc.24933
31. W Stummer U Pichlmeier T Meinel ALA-Glioma Study Group, et al. 2006 Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 392 401 10.1016/S1470-2045(06)70665-9 1:CAS:528:DC%2BD28XjvFWlsb0%3D 16648043
32. D Xue RE Albright Jr 1999 Preoperative anaplastic glioma tumor volume effects on patient survival J Surg Oncol 72 199 205 10.1002/(SICI)1096- 9098(199912)72:4<199::AID-JSO4>3.0.CO;2-O 1:STN:280: DC%2BD3c%2FlslyrsQ%3D%3D 10589034 (Pubitemid 30007788)
33. M Nakada KL Drake S Nakada, et al. 2006 Ephrin-B3 ligand promotes glioma invasion through activation of Rac1 Cancer Res 66 8492 8500 10.1158/0008-5472. CAN-05-4211 1:CAS:528:DC%2BD28XovF2isbY%3D 16951161 (Pubitemid 44449162)
34. M Deckert G Reifenberger W Wechsler 1989 Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67 J Cancer Res Clin Oncol 115 179 188 10.1007/BF00397921 1:STN:280:DyaL1M3jsVWnsA%3D%3D 2715168 (Pubitemid 19109378)
35. CL Hitchcock 1991 Ki-67 staining as a means to simplify analysis of tumor cell proliferation Am J Clin Pathol 96 444 446 1:STN:280:DyaK3MzmvVOksw%3D%3D 1716412
36. IK Mellinghoff MY Wang I Vivanco, et al. 2005 Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors N Engl J Med 353 2012 2024 10.1056/NEJMoa051918 1:CAS:528:DC%2BD2MXht1SrtrrE 16282176 (Pubitemid 41609094)
37. DA Hilton S Love R Barber, et al. 1998 Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy Neurosurgery 42 724 729 10.1097/00006123-199804000-00021 1:STN:280:DyaK1c3jtlyhsA%3D%3D 9574635 (Pubitemid 28208355)
38. M Dowsett AK Dunbier 2008 Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer Clin Cancer Res 14 8019 8026 10.1158/1078-0432.CCR-08-0974 1:CAS:528:DC%2BD1cXhsV2it7rM 19088018
39. V Donati G Fontanini M Dell'Omodarme, et al. 2007 WWOX expression in different histologic types and subtypes of non-small cell lung cancer Clin Cancer Res 13 884 891 10.1158/1078-0432.CCR-06-2016 1:CAS:528: DC%2BD2sXhsVyrs7Y%3D 17289881 (Pubitemid 46340363)
40. PH Tan BH Bay G Yip, et al. 2005 Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death Mod Pathol 18 374 381 10.1038/modpathol.3800254 1:CAS:528:DC%2BD2MXhtlertbo%3D 15578079 (Pubitemid 40395356)
41. E Galanis J Buckner D Kimmel, et al. 1998 Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas Int J Oncol 13 717 724 1:CAS:528:DyaK1cXmsVClurg%3D 9735401
42. T Sano H Lin X Chen, et al. 1999 Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis Cancer Res 59 1820 1824 1:CAS:528:DyaK1MXislejsb4%3D 10213484
43. L Frederick XY Wang G Eley, et al. 2000 Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas Cancer Res 60 1383 1387 1:CAS:528:DC%2BD3cXhvFWrtLw%3D 10728703
44. MJ McGirt KL Chaichana M Gathinji, et al. 2009 Independent association of extent of resection with survival in patients with malignant brain astrocytoma J Neurosurg 110 156 162 10.3171/2008.4.17536 18847342
45. Medical Research Council Brain Tumor Working Party 2001 Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma. A Medical Research Council trial J Clin Oncol 19 509 518